AUDREA SHERMAN: Open Payments
NPI 1114400942 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 35 payments from 10 companies in 2025. Trend: 2023 $410 · 2024 $302 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 20 | $353 |
| Valinor Pharma, LLC | 3 | $69 |
| PFIZER INC. | 3 | $63 |
| ABBVIE INC. | 2 | $47 |
| Orexo US, Inc. | 2 | $43 |
| Lilly USA, LLC | 1 | $29 |
| Fidia Pharma USA Inc. | 1 | $25 |
| SCILEX PHARMACEUTICALS INC. | 1 | $19 |
| Tonix Medicines, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: XTAMPZA, MOVANTIK, NURTEC ODT, Belbuca, Zubsolv, ZEPBOUND, TRILURON, QULIPTA.
Industry payments across MD — which companies pay providers there.
